Profil
Einat Brill-Almon worked as Director of Research & Development at Medgenics Medical (Israel) Ltd. from 2001 to 2004.
She then worked at Protalix Biotherapeutics, Inc. from 2004 to 2022, where she held the position of Senior Vice President & Chief Development Officer from 2020 to 2022.
Prior to that, she was Senior Vice President of Product Development at Protalix Ltd. Dr. Brill-Almon received her undergraduate degree from The Hebrew University of Jerusalem and her graduate and doctorate degrees from the Weizmann Institute of Science.
Tidigare kända positioner av Einat Brill-Almon
| Företag | Position | Slut |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Företagsledare/Principal | 2022-04-01 |
Medgenics Medical (Israel) Ltd.
Medgenics Medical (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops protein delivery technology | Teknisk/Vetenskaplig/F&U Direktör | 2004-01-01 |
Protalix Ltd. | Företagsledare/Principal | - |
Einat Brill-Almons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Medgenics Medical (Israel) Ltd.
Medgenics Medical (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops protein delivery technology | Commercial Services |
Protalix Ltd. |
















